Active ingredients: tipranavir
What it is used for
APTIVUS (tipranavir), co-administered with low dose ritonavir, is indicated for combination treatment of HIV infection in antiretroviral treatment experienced adults and adolescents aged 12 years and older, with evidence of viral replication, who have HIV-1 strains resistant to more than one protease inhibitor.,In deciding to initiate therapy with APTIVUS/ritonavir, careful consideration should be given to treatment history of the individual patient and the patterns of mutations associated with different agents. Genotypic testing should be performed to guide the use of APTIVUS.
How to take it
The way to take this medicine is: Oral. This medicine is taken by mouth.
- Store at 2 to 8 degrees Celsius
- Do not Freeze
- Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Pink, oblong, soft gelatin capsules imprinted in black with 'TPV 250'
Images are the copyright of the Pharmacy Guild of Australia
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on July 1, 2020. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy?
For the active ingredient tipranavir
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Consumer Medicines Information (CMI)
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems